IRVINE, Calif., April 15 /PRNewswire-FirstCall/ -- Edwards Lifesciences Corporation , a global leader in products and technologies to treat advanced cardiovascular disease, plans to announce its operating results for the quarter ended March 31, 2008 after the market closes on Tuesday, April 22, 2008 and will host a conference call at 5:00 p.m. ET that day to discuss its results.
To participate in the conference call, dial (877) 407-8037 or (201) 689-8037. For 72 hours following the call, an audio replay can be accessed by dialing (877) 660-6853 or (201) 612-7415 and using account number 2995 and conference number 279431. The call will also be available via live or archived webcast on the “Investor Relations” section of the Edwards web site at http://www.edwards.com or http://www.edwards.com/InvestorRelations/EventCalendar.htm.
About Edwards Lifesciences
Edwards Lifesciences, a leader in advanced cardiovascular disease treatments, is the number-one heart valve company in the world and the global leader in acute hemodynamic monitoring. Headquartered in Irvine, Calif., Edwards focuses on specific cardiovascular disease states including heart valve disease, vascular disease and critical care technologies. The company’s global brands, which are sold in approximately 100 countries, include Carpentier-Edwards, Cosgrove-Edwards, FloTrac, Fogarty, PERIMOUNT Magna and Swan-Ganz. Additional company information can be found at http://www.edwards.com.
Edwards is a trademark of Edwards Lifesciences Corporation. Edwards Lifesciences, Carpentier-Edwards, Cosgrove-Edwards, FloTrac, Fogarty, PERIMOUNT Magna and Swan-Ganz are trademarks of Edwards Lifesciences Corporation and are registered in the U.S. Patent and Trademark Office.
CONTACT: Media, Amanda Fowler, +1-949-250-5070, or Investors, David K.
Erickson, +1-949-250-6826, both of Edwards Lifesciences Corporation
Web site: http://www.edwards.com/
